Floatz logo

(±)-FTC

Poor Quality Sleep

Azienda Ospedaliera San Gerardo di MonzaSmall moleculePhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Poor Quality Sleep cohort.

Asset / SponsorPhaseRating
TENOFOVIR DISOPROXIL FUMARATE
Azienda Ospedaliera San Gerardo di Monza
Phase 4BB
ZOLPIDEM
Astellas Pharma Inc
Phase 3BB
Suvorexant
Merck Sharp & Dohme LLC
Phase 3BB
fk199b
Astellas Pharma Inc
Phase 3BB
Modafinil
VA Palo Alto Health Care System
Phase 4B

View all 12 →

Same molecule, other indications

(±)-FTC is also rated in:

HIV infectious diseaseDormant
BB
Indicative ·
71 / 100
View asset →
HIV infectious diseaseDormant
BB
Indicative ·
66 / 100
View asset →
fatty liver diseaseDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →